Literature DB >> 34410483

Morphological differences of choroid in central serous chorioretinopathy determined by ultra-widefield optical coherence tomography.

Takahiko Izumi1, Ichiro Maruko2, Taizo Kawano1, Manabu Sakaihara3, Tomohiro Iida1.   

Abstract

PURPOSE: The purpose of this study was to compare the morphology of the central and peripheral choroid of eyes with central serous chorioretinopathy (CSC) to that of normal eyes using ultra-widefield optical coherence tomography (UWF-OCT).
METHODS: We reviewed the medical records of 29 eyes of 25 patients (23 men, 2 women; average age 44.4 years) with CSC and 34 eyes of 22 healthy subjects (19 men, 3 women; average age, 49.5 years) with normal eyes. The images obtained by a prototype swept source UWF-OCT (Topcon, Tokyo, Japan) of about 31.5-mm wide and a depth of 10.9 mm were analyzed. The choroidal thickness was measured for each sector of the eye using the conventional automated layer analysis method. The local morphological differences were quantified by the maximum steepness (µm/deg) which was obtained by differentiating the changes in the choroidal thickness from the periphery to the fovea. Only the vertical scans were evaluated to avoid the influence of the optic disc.
RESULTS: The choroid was thicker in the macular area than the peripheral area in both normal and CSC eyes. The choroid at the subfovea was significantly thicker in the CSC eyes than that of the normal eyes (P < 0.0001); however, the difference at the periphery was not significant. The mean of the maximum steepness of the choroidal thickness was 20.8 ± 3.8 µm/deg in the CSC eyes which was significantly steeper than the 16.0 ± 4.6 µm/deg in healthy eyes (P < 0.0001).
CONCLUSION: The choroid in CSC eyes has a steeper slope around the posterior pole. UWF-OCT can be used to evaluate the abnormalities of the choroidal structures from the posterior pole to the periphery in eyes with CSC.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Central serous chorioretinopathy; Choroid; Optical coherence tomography; Ultra-widefield OCT

Mesh:

Year:  2021        PMID: 34410483     DOI: 10.1007/s00417-021-05380-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  19 in total

1.  Enhanced depth imaging spectral-domain optical coherence tomography.

Authors:  Richard F Spaide; Hideki Koizumi; Maria C Pozzoni; Maria C Pozonni
Journal:  Am J Ophthalmol       Date:  2008-07-17       Impact factor: 5.258

2.  Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.

Authors:  Ichiro Maruko; Tomohiro Iida; Yukinori Sugano; Akira Ojima; Tetsuju Sekiryu
Journal:  Retina       Date:  2011-09       Impact factor: 4.256

3.  Type A behavior and central serous chorioretinopathy.

Authors:  L A Yannuzzi
Journal:  Trans Am Ophthalmol Soc       Date:  1986

4.  Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy.

Authors:  T Iida; S Kishi; N Hagimura; K Shimizu
Journal:  Retina       Date:  1999       Impact factor: 4.256

5.  Visualization of sub-retinal pigment epithelium morphologies of exudative macular diseases by high-penetration optical coherence tomography.

Authors:  Yoshiaki Yasuno; Masahiro Miura; Keisuke Kawana; Shuichi Makita; Masaki Sato; Fumiki Okamoto; Masahiro Yamanari; Takuya Iwasaki; Toyohiko Yatagai; Tetsuro Oshika
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-01       Impact factor: 4.799

6.  Central serous chorioretinopathy and indocyanine green angiography.

Authors:  F C Piccolino; L Borgia
Journal:  Retina       Date:  1994       Impact factor: 4.256

7.  Digital indocyanine green videoangiography of central serous chorioretinopathy.

Authors:  D R Guyer; L A Yannuzzi; J S Slakter; J A Sorenson; A Ho; D Orlock
Journal:  Arch Ophthalmol       Date:  1994-08

8.  Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy.

Authors:  Yutaka Imamura; Takamitsu Fujiwara; Ron Margolis; Richard F Spaide
Journal:  Retina       Date:  2009 Nov-Dec       Impact factor: 4.256

9.  Corticosteroids and central serous chorioretinopathy.

Authors:  Cynthia A Carvalho-Recchia; Lawrence A Yannuzzi; Silvana Negrão; Richard F Spaide; K Bailey Freund; Hanna Rodriguez-Coleman; Marcio Lenharo; Tomohiro Iida
Journal:  Ophthalmology       Date:  2002-10       Impact factor: 12.079

10.  Choroidal capillary and venous congestion in central serous chorioretinopathy.

Authors:  C Prünte; J Flammer
Journal:  Am J Ophthalmol       Date:  1996-01       Impact factor: 5.258

View more
  1 in total

1.  Bilateral Pachychoroid disease with type 3 Uveal effusion syndrome in one eye and central serous Chorioretinopathy in contralateral eye: a case report.

Authors:  Hajime Onoe; Hiroyuki Shimada; Akiyuki Kawamura; Hiromi Hirosawa; Koji Tanaka; Ryusaburo Mori; Hiroyuki Nakashizuka
Journal:  BMC Ophthalmol       Date:  2022-02-23       Impact factor: 2.209

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.